Healthcare Partners Collaborate To Broaden Access To Lung Cancer Diagnosis With Artificial Intelligence Technology
Lung Cancer Network Malaysia (LCNM) and AstraZeneca launched another strategic collaboration to broaden access to lung cancer diagnosis utilising advanced technologies
